Greenlight Capital Re Stock Forecast, Price & News

Wall Street analysts have given Greenlight Capital Re a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Greenlight Capital Re wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Greenlight Capital Re saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,550,000 shares, an increase of 164.4% from the March 15th total of 964,400 shares. Based on an average trading volume of 197,900 shares, the short-interest ratio is presently 12.9 days. Approximately 9.6% of the shares of the company are short sold.
View Greenlight Capital Re's Short Interest.

Greenlight Capital Re is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Greenlight Capital Re.

Greenlight Capital Re, Ltd. (NASDAQ:GLRE) issued its earnings results on Tuesday, March, 9th. The financial services provider reported $1.20 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.68 by $0.52. The financial services provider had revenue of $130.90 million for the quarter. Greenlight Capital Re had a negative net margin of 16.48% and a negative trailing twelve-month return on equity of 15.47%.
View Greenlight Capital Re's earnings history.

Greenlight Capital Re's stock was trading at $7.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GLRE stock has increased by 25.4% and is now trading at $9.03.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Greenlight Capital Re include Everest Re Group (RE), Alleghany (Y), Reinsurance Group of America (RGA), RenaissanceRe (RNR), Enstar Group (ESGR) and Maiden (MHLD).
View all of GLRE's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlight Capital Re investors own include Third Point Reinsurance (TPRE), (OAS), Pfizer (PFE), Ford Motor (F), Idera Pharmaceuticals (IDRA), Advanced Micro Devices (AMD), Intel (INTC), American International Group (AIG), Chevron (CVX) and Enterprise Products Partners (EPD).

Greenlight Capital Re trades on the NASDAQ under the ticker symbol "GLRE."

Greenlight Capital Re's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FNY Investment Advisers LLC (0.03%).
View institutional ownership trends for Greenlight Capital Re.

GLRE stock was sold by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC.
View insider buying and selling activity for Greenlight Capital Re or view top insider-selling stocks.

Shares of GLRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GLRE stock can currently be purchased for approximately $9.03.

Greenlight Capital Re has a market capitalization of $317.76 million and generates $538.15 million in revenue each year.

Greenlight Capital Re employs 35 workers across the globe.

The official website for Greenlight Capital Re is www.greenlightre.ky.

Greenlight Capital Re is headquartered at 65 MARKET STREET SUITE 1207 CAMANA BAY P.O. BOX 31110, GRAND CAYMAN E9, KY1-1205.

Greenlight Capital Re's mailing address is 65 MARKET STREET SUITE 1207 CAMANA BAY P.O. BOX 31110, GRAND CAYMAN E9, KY1-1205. The financial services provider can be reached via phone at 34-59-434-57 or via email at [email protected]